At a glance
- Originator Kowa
- Class Antihypertensives
- Mechanism of Action Endothelin B receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 04 Dec 2003 No development reported - Preclinical for Heart failure in Japan (unspecified route)
- 01 Aug 2000 Preclinical development for Heart failure in Japan (Unknown route)